India may issue warning against Marion's cough syrup exports

Published Date: 08 Mar 2023

India may issue a warning over cough syrup exported by Marion Biotech linked to a death in Uzbekistan.

Read Full News

Latest News

Gross Hematuria After COVID Vaccination Linked to Short-Term Kidney Function Decline in IgAN Abigail Brooks, MA

Increases in short-term kidney function decline were observed following post-COVID-19 vaccination gross hematuria in individuals with IgA nephropathy.

Navigating Treatment Decisions In IgAN, With Jai Radhakrishnan, MD Jai Radhakrishnan, MD

Radhakrishnan emphasizes the importance of individualized IgAN care and how to best use currently available and emerging treatments.

APPEAR-C3G: Iptacopan Shows Proteinuria Reduction, eGFR Benefits in C3G Abigail Brooks, MA

The phase 3 data reinforce iptacopan’s safety and efficacy in C3G and support its recent US Food and Drug Administration approval for this indication.

APPLAUSE-IgAN: Iptacopan (Fabhalta) Meets eGFR Decline Primary Endpoint Abigail Brooks, MA

Final results from APPLAUSE-IgAN demonstrate iptacopan’s superiority versus placebo for slowing IgAN progression and will be used to support its full approval.

FDA Approves Obinutuzumab (Gazyva) for Lupus Nephritis Abigail Brooks, MA

The decision is supported by positive results from the phase 2 NOBILITY and phase 3 REGENCY studies.

Enhancing Perceived Behavioral Control May Improve Post-Transplant Medication Adherence Alex Hillenbrand

Perceived behavioral control emerged as a predictor of immunosuppression adherence after kidney transplantation, pointing to practical intervention targets.

Todays Updates

Building the Next Era of ALS Clinical Research and Trials Marco Meglio

Ryan Donaghy, MD, an assistant professor of neurology at Northwestern Medicine, discussed the evolving landscape of ALS clinical trials, including advances in biomarkers, genetics, and modern trial design.

Treating Obstructive Sleep Apnea: Beyond CPAP and Toward Hypoglossal Nerve Stimulation Vaishal Shah, MD, MPH, FAASM, FAAP

Vaishal Shah, MD, MPH, FAASM, FAAP, center director of the Sleep Disorders Center at Cleveland Clinic, spoke on the changes in how obstructive sleep apnea is treated, moving away from CPAP to more novel approaches.

Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD Isabella Ciccone, MPH

In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing neuromyelitis optica spectrum disorder in Saudi Arabia.

Understanding Atacicept & 36-Week ORIGIN 3 Data from Kidney Week 2025, With Jonathan Barratt, MBChB, PhD Jonathan Barratt, MBChB, PhD, FRCP

Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Todays Updates

Building the Next Era of ALS Clinical Research and Trials Marco Meglio

Ryan Donaghy, MD, an assistant professor of neurology at Northwestern Medicine, discussed the evolving landscape of ALS clinical trials, including advances in biomarkers, genetics, and modern trial design.

Treating Obstructive Sleep Apnea: Beyond CPAP and Toward Hypoglossal Nerve Stimulation Vaishal Shah, MD, MPH, FAASM, FAAP

Vaishal Shah, MD, MPH, FAASM, FAAP, center director of the Sleep Disorders Center at Cleveland Clinic, spoke on the changes in how obstructive sleep apnea is treated, moving away from CPAP to more novel approaches.

Expert Panel Publishes Revised Consensus Recommendations for Diagnosis and Management of NMOSD Isabella Ciccone, MPH

In a newly published study, researchers developed expert-driven, evidence-based, up-to-date consensus recommendations for managing neuromyelitis optica spectrum disorder in Saudi Arabia.

Understanding Atacicept & 36-Week ORIGIN 3 Data from Kidney Week 2025, With Jonathan Barratt, MBChB, PhD Jonathan Barratt, MBChB, PhD, FRCP

Jonathan Barratt, MBChB, PhD, discusses 36-week atacicept data from ASN Kidney Week 2025.

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Exploring the New COPD Era: Biologics, Guidelines, and Real-World Barriers

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Telitacicept Achieves Primary Endpoint in IgA Nephropathy Phase 3 Study

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Pre-Conception Hypertension Linked to Adverse Pregnancy Outcomes in IgA Nephropathy

Latest News

Increases in short-term kidney function decline were observed following post-COVID-19 vaccination gross hematuria in individuals with IgA nephropathy.

Radhakrishnan emphasizes the importance of individualized IgAN care and how to best use currently available and emerging treatments.

The phase 3 data reinforce iptacopan’s safety and efficacy in C3G and support its recent US Food and Drug Administration approval for this indication.

Final results from APPLAUSE-IgAN demonstrate iptacopan’s superiority versus placebo for slowing IgAN progression and will be used to support its full approval.

The decision is supported by positive results from the phase 2 NOBILITY and phase 3 REGENCY studies.

Perceived behavioral control emerged as a predictor of immunosuppression adherence after kidney transplantation, pointing to practical intervention targets.

News All Time

Anxiety, Depression Linked to Poor Sleep Quality in ESRD Patients on HD Alex Hillenbrand

Findings showed anxiety, depression, and sleep disorders were highly prevalent among ESRD patients undergoing maintenance hemodialysis

FINE-ONE: Finerenone Proves Benefit in Type 1 Diabetes and CKD Patrick Campbell

Finerenone significantly reduces UACR in type 1 diabetes patients with chronic kidney disease, offering new hope for treatment.

Kidney Week 2025: ORIGIN 3 Sets the Stage for Atacicept in IgA Nephropathy Patrick Campbell

Phase 3 trial results reveal atacicept significantly reduces proteinuria in IgA nephropathy, paving the way for potential FDA approval in 2026.

Almost All Adults With Hypertensive CKD Would Benefit From Lower Blood Pressure Target

Almost All Adults With Hypertensive CKD Would Benefit From Lower Blood Pressure Target

PISCES: Fish Oil Slashes Cardiovascular Event Risk of Maintenance Dialysis Victoria Johnson

New data on daily fish oil supplementation prompts discussions on clinical recommendations.

BESTOW: Tegoprubart Showcases Safer Prevention of Kidney Transplant Rejection Over Tacrolimus Victoria Johnson

Tegoprubart shows promise as a safer alternative to tacrolimus in kidney transplants, enhancing graft function with fewer side effects.

DUPLEX: Sparsentan Outperforms Irbesartan in Reaching Key Proteinuria Threshold in FSGS Victoria Johnson

New findings reveal sparsentan significantly reduces proteinuria in FSGS patients, offering hope for improved kidney health and lower failure risk.

Uptrend in Acute Kidney Injury Mortality in Higher Socioeconomic Countries Projected to Continue

Uptrend in Acute Kidney Injury Mortality in Higher Socioeconomic Countries Projected to Continue

Sibeprenlimab Safely Reduces Gd-IgA1, Other IgAN Markers, in New Analysis

Sibeprenlimab Safely Reduces Gd-IgA1, Other IgAN Markers, in New Analysis

Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates

Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates

FDA Clears IND Application for EGEN-2784, a Genetically Engineered Pig Kidney, for ESKD

FDA Clears IND Application for EGEN-2784, a Genetically Engineered Pig Kidney, for ESKD

Hypertensive Kidney Disease Death Rate Up 48% in Past 25 Years

Hypertensive Kidney Disease Death Rate Up 48% in Past 25 Years

6 Nephrology Headlines You Missed in August 2025

6 Nephrology Headlines You Missed in August 2025

Pegcetacoplan's Approval and Shifting C3G Landscape, with Sayna Norouzi, MD

C3G treatment options expand with FDA approvals of pegcetacoplan and iptacopan, offering new hope for patient care.

HCPLive 5 Stories in Under 5: Week of 08/24

HCPLive 5 Stories in Under 5: Week of 08/24

Vancomycin Use in ICU Incurs Greater AKI Risk Than Alternative Antibiotics

Vancomycin Use in ICU Incurs Greater AKI Risk Than Alternative Antibiotics

Recommended News For You

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

Higher Binge Drinking Rates Linked to New Cannabis Laws.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

enhancing survivors of brain tumors' quality of life.

Experts Debate AQUILA Trial Findings in Smoldering Multiple Myeloma

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Recommended Articles For You

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients 

Different Types of Blood Dyscrasias  

Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential 

Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Brain cancer: a Q&A session.

3.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

4.

Daily physical activity, even at light intensities, linked to lower cancer risk

5.

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

1.

A Revolutionary Guide to Calculating Absolute Neutrophil Counts

2.

Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research

3.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

4.

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment

5.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

3.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot